Taibei, China – On January 12, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") received the regulatory approval from Taiwan Food and Drug Administration ("TFDA") for its in-house developed Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"). It is the first drug-eluting stent in MicroPort® and the whole Chinese mainland that successfully gained the regulatory approval in Taiwan, marking a milestone in the development of MicroPort®'s cardiovascular business segment.
Firehawk® is the world's first and only target-eluting stent ("TES"). It is a new-generation drug-eluting stent of MicroPort® for the treatment of coronary artery stenosis or occlusion after Firebird® Rapamycin-Eluting Coronary CoCr Stent System ("Firebird®") and Firebird2® Rapamycin-Eluting Coronary CoCr Stent System ("Firebird2®"). Firehawk® adopts TES Technology platform, and its coating area is only 20% of the stent surface. Firehawk®'s drug is released over 90 days and its polymer is fully absorbed in nine months. Its average metal coverage rate is 14.0-16.1%. Firehawk® is the world's lowest drug dosage stent, with only 1/3 dosage versus similar products while achieving the same efficacy.
With the increasing aging population, the incidence rate of coronary disease is constantly growing in Taiwan. According to statistics, there are around 30,000 PCI cases in the Taiwan market annually and the demand for coronary stent is rapidly increasing. After around two years' effort, MicroPort® successfully gained the regulatory approval of Firehawk® in the Taiwan market, signifying a major step forward for the company's market development in Taiwan. With its outstanding performance, it is expected that Firehawk® will provide more ideal cardiovascular treatment for local patients and help enhance the communication between cardiologists from Taiwan and the mainland as well.
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.